Literature DB >> 8973477

Diffuse brain invasion of glioma cells requires beta 1 integrins.

W Paulus1, I Baur, A S Beutler, S A Reeves.   

Abstract

Diffuse invasion of brain tissue by single tumor cells is a characteristic feature of gliomas and a major reason why these tumors cannot be completely resected. The molecular basis of brain invasion is poorly understood. We regulated the expression of beta 1 integrins, the major group of extracellular matrix receptors, in astrocytic tumor cells by using a tetracycline-dependent transcription control system. Rat C6 glioma cells were stably transfected with (a) the tetracycline-controlled transactivator (tTA) gene, (b) antisense beta 1 cDNA under the control of a tTA/tetracycline-responsive promoter, and (c) the beta-galactosidase (lacZ) gene for histochemical identification. In one clone, C6TL beta, beta 1 protein levels were unaffected in the presence of tetracycline, but they were reduced by 60% in the absence of tetracycline because of production of antisense mRNA. C6TL beta cells were transplanted into the striatum of nude mice. After 14 days in the presence of tetracycline in the drinking water, tumors showed diffuse brain invasion, mainly along vascular basement membranes. In the absence of tetracycline, however, tumor cells were compact and generally well delineated from the surrounding brain tissue. These data, ie, blocking of brain invasion by antisense beta 1 mRNA, either because of disturbed interaction of beta 1 with brain extracellular matrix components or interference with beta 1-dependent signaling pathways, strongly suggest that beta 1 integrins are required for diffuse brain invasion of gliomas.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8973477

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  31 in total

1.  The tyrosine kinase pyk2 promotes migration and invasion of glioma cells.

Authors:  Christopher A Lipinski; Nhan L Tran; Emmanuel Menashi; Carole Rohl; Jean Kloss; R Curtis Bay; Michael E Berens; Joseph C Loftus
Journal:  Neoplasia       Date:  2005-05       Impact factor: 5.715

Review 2.  Biological mechanisms of glioma invasion and potential therapeutic targets.

Authors:  B B Tysnes; R Mahesparan
Journal:  J Neurooncol       Date:  2001-06       Impact factor: 4.130

3.  A composite hydrogel platform for the dissection of tumor cell migration at tissue interfaces.

Authors:  Andrew D Rape; Sanjay Kumar
Journal:  Biomaterials       Date:  2014-07-19       Impact factor: 12.479

4.  Neural cell adhesion molecule L1 in gliomas: correlation with TGF-beta and p53.

Authors:  T Tsuzuki; S Izumoto; T Ohnishi; S Hiraga; N Arita; T Hayakawa
Journal:  J Clin Pathol       Date:  1998-01       Impact factor: 3.411

5.  MMP inhibitor Ilomastat induced amoeboid-like motility via activation of the Rho signaling pathway in glioblastoma cells.

Authors:  Shaofeng Yan; Hao Xue; Ping Zhang; Xiao Han; Xing Guo; Guang Yuan; Lin Deng; Gang Li
Journal:  Tumour Biol       Date:  2016-10-14

6.  Overexpression of ST6GalNAcV, a ganglioside-specific alpha2,6-sialyltransferase, inhibits glioma growth in vivo.

Authors:  Roger A Kroes; Huan He; Mark R Emmett; Carol L Nilsson; Franklin E Leach; I Jonathan Amster; Alan G Marshall; Joseph R Moskal
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-28       Impact factor: 11.205

7.  Regulatory effect of nerve growth factor in alpha9beta1 integrin-dependent progression of glioblastoma.

Authors:  Meghan C Brown; Izabela Staniszewska; Philip Lazarovici; George P Tuszynski; Luis Del Valle; Cezary Marcinkiewicz
Journal:  Neuro Oncol       Date:  2008-12       Impact factor: 12.300

8.  Mesenchymal migration as a therapeutic target in glioblastoma.

Authors:  Jessie Zhong; Andre Paul; Stewart J Kellie; Geraldine M O'Neill
Journal:  J Oncol       Date:  2010-06-21       Impact factor: 4.375

9.  Galectin-1 is implicated in the protein kinase C epsilon/vimentin-controlled trafficking of integrin-beta1 in glioblastoma cells.

Authors:  Shannon Fortin; Marie Le Mercier; Isabelle Camby; Sabine Spiegl-Kreinecker; Walter Berger; Florence Lefranc; Robert Kiss
Journal:  Brain Pathol       Date:  2009-10-08       Impact factor: 6.508

Review 10.  Galectins and gliomas.

Authors:  Marie Le Mercier; Shannon Fortin; Véronique Mathieu; Robert Kiss; Florence Lefranc
Journal:  Brain Pathol       Date:  2009-04-07       Impact factor: 6.508

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.